In8Bio Inc (INAB) Stock Price, Quote & News

Company Profile

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases. Its products include INB-400, which is in Phase 2 clinical trial to treat newly diagnosed glioblastoma (GBM); INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of GBM; and INB-100, an allogeneic product ca...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 600 6438

Website: in8bio.com

Address:

350 5th Avenue, Suite 5330, New York, United States

SmartMoneyPicks Sep. 13 at 6:01 AM

MITQ has all the ingredients needed for a parabolic move. What a bullish close Friday, on our way to 52 weeks high and then it's going to squeeze up fast. MITQ 💥 Small float 💥 NO Dilution 💥 Cash-Flow Positive 💥 High Insider Ownership 💥 golden cross forming on the daily-Bullish. The chart is looking explosive, you don't want to miss out on this one! Lets go bulls be early next week. Also watching: $CPPOP $BFRG $INAB $MDVL

0 · Reply

BigSqueezeComing Sep. 11 at 9:34 AM

$INAB pm gapper

0 · Reply

3ARated Sep. 9 at 3:02 PM

$INAB He wrote the same thing about IMNN

0 · Reply

aw20 Sep. 9 at 2:46 PM

$INAB back in at 2 🧐

0 · Reply

dogood Sep. 5 at 10:44 AM

$INAB should have been $10, hope runs

1 · Reply

NVDAMillionaire Sep. 3 at 1:53 PM

$INAB Really good write-up that perfectly summarizes INAB's present situation. So if you want to bring your INAB knowledge up to date or just discover INAB, this is required reading. https://beyondspx.com/quote/INAB/in8bio-pioneering-gamma-delta-t-cells-amidst-a-critical-funding-juncture-nasdaq-inab#analysis

0 · Reply